"clinical outcomes according" trang 7 - tải miễn phí từ tailieunhanh
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer

Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer
11    92    0
Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection

Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection
15    92    0
The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: A retrospective study

The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: A retrospective study
13    62    1
LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR1179/HMGB3 axis

LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR1179/HMGB3 axis
11    76    0
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: A retrospective study

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: A retrospective study
10    63    0
Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer

Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer
7    84    0
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: An observational study

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: An observational study
10    51    1
The outcomes and prognostic factors in patients with osteosarcoma according to age: A Japanese nationwide study with focusing on the age differences

The outcomes and prognostic factors in patients with osteosarcoma according to age: A Japanese nationwide study with focusing on the age differences
7    51    1
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
13    63    1
A novel chemotherapeutic sensitivitytesting system based on collagen gel droplet embedded 3D–culture methods for hepatocellular carcinoma

A novel chemotherapeutic sensitivitytesting system based on collagen gel droplet embedded 3D–culture methods for hepatocellular carcinoma
8    63    1
LINC00511 as a prognostic biomarker for human cancers: A systematic review and meta-analysis

LINC00511 as a prognostic biomarker for human cancers: A systematic review and meta-analysis
12    42    1
Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer

Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer
9    79    1
Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinumbased chemotherapy: A meta-analysis based on the PRISMA statement

Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinumbased chemotherapy: A meta-analysis based on the PRISMA statement
13    59    1
Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States

Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States
12    30    1
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
7    60    1
Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes

Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes
14    62    1
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea
8    46    1
Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers

Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers
13    38    1
Data mining of digitized health records in a resource-constrained setting reveals that timely immunophenotyping is associated with improved breast cancer outcomes

Data mining of digitized health records in a resource-constrained setting reveals that timely immunophenotyping is associated with improved breast cancer outcomes
10    83    1
An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types

An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types
15    56    1